Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study
Open Access
- 11 March 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (6), 1003-1009
- https://doi.org/10.1016/j.jcf.2021.02.011
Abstract
No abstract availableKeywords
Funding Information
- Chiesi Farmaceutici
This publication has 30 references indexed in Scilit:
- Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosisJournal of Cystic Fibrosis, 2013
- Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety studyEuropean Respiratory Journal, 2011
- Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trialJournal of Cystic Fibrosis, 2011
- Inhaled Mannitol Improves the Hydration and Surface Properties of Sputum in Patients With Cystic FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-managementJournal of Cystic Fibrosis, 2009
- Microbial contamination of nebulizers in the home treatment of cystic fibrosisChild: Care, Health and Development, 2006
- Simple procedures for blinded sample size adjustment that do not affect the type I error rateStatistics in Medicine, 2003
- The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot studyEuropean Respiratory Journal, 1999
- Determinants of Mortality from Cystic Fibrosis in Canada, 1970-1989American Journal of Epidemiology, 1996
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisThe New England Journal of Medicine, 1994